$225 Infusion More IV Infusions There's an IV drip for everyone
human clinical trials ongoing as of 2026 Search volume: 165,000 monthly US searches most searched non-weight-loss peptide Legal status: Category 1 compounding (legal under physician prescription, as of February 2026) Administration: Subcutaneous injection or oral/sublingual (gut applications) An honest note on the evidence: The majority of BPC-157 research has been conducted in animal models rats and mice primarily
If you add 2mL of bacteriostatic water to a 5mg vial, your concentration is 2.5mg/mL
Most patients begin here and stay here, as the 5mg dose is sufficient for meaningful cognitive benefits in the majority of cases
Reduces Hyperpigmentation- Glutathiones lightening skin tone reduces hyperpigmentation, including age and sun spots
Theoretically, combining it with cagrilintide could provide triple-mechanism coverage: amylin receptor activation (cagrilintide) plus GIP and GLP-1 receptor activation (tirzepatide)